Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SaeRS two-component system is a highly conserved bacterial regulatory complex present in multiple Gram-positive pathogens, including *Staphylococcus aureus* and Group B *Streptococcus*. Comprised of the sensor histidine kinase **SaeS** and the response regulator **SaeR**, with auxiliary proteins SaeP and SaeQ in S. aureus, this system enables bacteria to sense environmental stimuli and adjust the transcription of over twenty critical virulence factors such as hemolysins, leukocidins, superantigens, surface proteins, and proteases[4][1][6]. SaeRS is essential for host colonization, immune response modulation, and the switch from commensal to invasive pathogenic states, with key roles in adhesion, invasion, and immune evasion[1][3][4][7]. The system achieves this by activating or suppressing specific genes in response to infection-related cues, thereby determining the outcome and severity of infections in humans. Given its centrality to pathogenesis, SaeRS is considered a high-value target for next-generation antibacterial therapies aiming to attenuate bacterial virulence without directly killing the pathogen, potentially reducing selective pressure for resistance[3][7][6].
Inhibition of histidine kinase activity (SaeS); Blockade or modification of response regulator phosphorylation (SaeR); Disruption of DNA binding by SaeR; Down-regulation of SaeRS-mediated virulence gene expression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SaeRS two-component system (SaeRS TCS).